GlassScriptPhysician profile
Tara L Hardin
NPI 1437167459
$2,157.27
in general payments reported to CMS, 2019-2025
20 companies · $402 in 2025
The $402 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $234 · 2021: $596 · 2022: $75.61 · 2023: $308 · 2024: $295 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $294.35 | 2019-2023 | |
| Alcon Vision LLC | $291.75 | 2021-2025 | Clareon, Clareon Panoptix Pro, Precision 1 |
| Allergan, INC. | $169.89 | 2020-2021 | |
| Astellas Pharma US INC | $161.31 | 2023-2025 | Izervay |
| Bausch & Lomb Americas INC. | $156.37 | 2022-2024 | Xiidra, Infuse, Vyzulta |
| Kala Pharmaceuticals, INC. | $142.23 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $140.20 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $110.12 | 2020-2021 | |
| Glaukos Corporation | $98.09 | 2019 | |
| Sun Pharmaceutical Industries INC. | $93.55 | 2020-2025 | Cequa |
| Johnson & Johnson Vision Care, INC. | $93.15 | 2019-2025 | |
| Abbvie INC. | $88.45 | 2023 | |
| Coopervision INC. | $71.56 | 2019-2025 | Myday Contact Lens |
| Aerie Pharmaceuticals, INC. | $66.20 | 2020-2021 | |
| Tarsus Pharmaceuticals, INC. | $55.29 | 2024-2025 | Xdemvy |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $43.35 | 2023 | Tyrvaya |
| Biotissue Holdings INC. | $21.52 | 2025 | |
| Harrow Eye, LLC | $20.83 | 2024 | Vevye |
| Thea Pharma INC. | $19.60 | 2023 | |
| Eyevance Pharmaceuticals LLC | $19.46 | 2023 | Flarex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Hardin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.